ROBERT HERSHBERG Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT HERSHBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT HERSHBERG. ROBERT HERSHBERG is Sr. VP & Chief Medical Officer in DENDREON CORP ($DNDN) and Director in NanoString Technologies Inc ($NSTG) and Director in Adaptive Biotechnologies Corp ($ADPT) and Director in RECURSION PHARMACEUTICALS, INC. ($RXRX).
Latest Insider Trading Transactions of ROBERT HERSHBERG
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADPT, DNDN, NSTG, RXRX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | A | 0.00 | 3,890 | 0 | 3,890 | |
Jun 17 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.00 | 5,520 | 0 | 0 | |
Jun 17 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Buy | M | 0.00 | 5,520 | 0 | 7,410 | 1.9 K to 7.4 K (+292.06 %) |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Option Exercise | C | 2.22 | 525,000 | 1,165,500 | 525,000 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Option Exercise | C | 2.22 | 525,000 | 1,165,500 | 0 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Option Exercise | C | 18.00 | 12,500 | 225,000 | 12,500 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Option Exercise | C | 18.00 | 12,500 | 225,000 | 0 | |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Buy | C | 0.00 | 6,250 | 0 | 6,250 | 0 to 6.3 K |
Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Sell | C | 0.00 | 6,250 | 0 | 0 | 6.3 K to 0 (-100.00 %) |
Apr 19 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Option Exercise | A | 18.00 | 12,500 | 225,000 | 12,500 | |
Apr 19 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Grant | A | 0.00 | 6,250 | 0 | 6,250 | 0 to 6.3 K |
Apr 19 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | M | 14.71 | 144 | 2,118 | 7,684 | |
Apr 19 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 74.20 | 118 | 8,756 | 1,890 | 2 K to 1.9 K (-5.88 %) |
Apr 19 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 72.87 | 19 | 1,385 | 2,008 | 2 K to 2 K (-0.94 %) |
Apr 19 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 71.75 | 7 | 502 | 2,027 | 2 K to 2 K (-0.34 %) |
Apr 19 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Buy | M | 14.71 | 144 | 2,118 | 2,034 | 1.9 K to 2 K (+7.62 %) |
Mar 17 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | M | 11.20 | 1,500 | 16,800 | 0 | |
Mar 17 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 67.16 | 1,214 | 81,532 | 1,890 | 3.1 K to 1.9 K (-39.11 %) |
Mar 17 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 66.03 | 282 | 18,620 | 3,104 | 3.4 K to 3.1 K (-8.33 %) |
Mar 17 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 63.58 | 4 | 254 | 3,386 | 3.4 K to 3.4 K (-0.12 %) |
Mar 17 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Buy | M | 11.20 | 1,500 | 16,800 | 3,390 | 1.9 K to 3.4 K (+79.37 %) |
Mar 10 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 53,000 | |
Mar 10 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 44.56 | 2,000 | 89,120 | 0 | 2 K to 0 (-100.00 %) |
Mar 10 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Mar 10 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 53,000 | |
Mar 10 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 44.56 | 2,000 | 89,120 | 1,504 | 3.5 K to 1.5 K (-57.08 %) |
Mar 10 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 3,504 | 1.5 K to 3.5 K (+132.98 %) |
Feb 18 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | M | 11.20 | 1,188 | 13,306 | 1,500 | |
Feb 18 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 83.93 | 69 | 5,791 | 1,890 | 2 K to 1.9 K (-3.52 %) |
Feb 18 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 82.83 | 163 | 13,501 | 1,959 | 2.1 K to 2 K (-7.68 %) |
Feb 18 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 81.79 | 156 | 12,759 | 2,122 | 2.3 K to 2.1 K (-6.85 %) |
Feb 18 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 80.55 | 159 | 12,807 | 2,278 | 2.4 K to 2.3 K (-6.52 %) |
Feb 18 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 79.53 | 323 | 25,688 | 2,437 | 2.8 K to 2.4 K (-11.70 %) |
Feb 18 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 78.40 | 318 | 24,931 | 2,760 | 3.1 K to 2.8 K (-10.33 %) |
Feb 18 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Buy | M | 11.20 | 1,188 | 13,306 | 3,078 | 1.9 K to 3.1 K (+62.86 %) |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 55,000 | |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | A | 66.50 | 3,759 | 249,974 | 3,759 | |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 65.45 | 2,000 | 130,900 | 1,504 | 3.5 K to 1.5 K (-57.08 %) |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 3,504 | 1.5 K to 3.5 K (+132.98 %) |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Grant | A | 0.00 | 1,504 | 0 | 1,504 | 0 to 1.5 K |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 57,000 | |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 67.05 | 622 | 41,705 | 0 | 622 to 0 (-100.00 %) |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 66.34 | 1,378 | 91,417 | 622 | 2 K to 622 (-68.90 %) |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Jan 19 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | M | 11.20 | 1,500 | 16,800 | 2,688 | |
Jan 19 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 74.55 | 90 | 6,710 | 1,890 | 2 K to 1.9 K (-4.55 %) |
Jan 19 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 73.66 | 291 | 21,435 | 1,980 | 2.3 K to 2 K (-12.81 %) |
Jan 19 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 72.91 | 410 | 29,893 | 2,271 | 2.7 K to 2.3 K (-15.29 %) |
Jan 19 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 71.77 | 709 | 50,885 | 2,681 | 3.4 K to 2.7 K (-20.91 %) |
Jan 19 2021 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Buy | M | 11.20 | 1,500 | 16,800 | 3,390 | 1.9 K to 3.4 K (+79.37 %) |
Dec 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 59,000 | |
Dec 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 57.01 | 241 | 13,739 | 0 | 241 to 0 (-100.00 %) |
Dec 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 55.78 | 1,759 | 98,117 | 241 | 2 K to 241 (-87.95 %) |
Dec 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Dec 16 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | M | 11.20 | 1,500 | 16,800 | 4,188 | |
Dec 16 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 69.88 | 812 | 56,743 | 1,890 | 2.7 K to 1.9 K (-30.05 %) |
Dec 16 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 68.68 | 688 | 47,252 | 2,702 | 3.4 K to 2.7 K (-20.29 %) |
Dec 16 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Buy | M | 11.20 | 1,500 | 16,800 | 3,390 | 1.9 K to 3.4 K (+79.37 %) |
Nov 18 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | M | 11.20 | 1,500 | 16,800 | 5,688 | |
Nov 18 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 47.03 | 746 | 35,084 | 1,890 | 2.6 K to 1.9 K (-28.30 %) |
Nov 18 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 46.31 | 754 | 34,918 | 2,636 | 3.4 K to 2.6 K (-22.24 %) |
Nov 18 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Buy | M | 11.20 | 1,500 | 16,800 | 3,390 | 1.9 K to 3.4 K (+79.37 %) |
Oct 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 63,000 | |
Oct 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 51.51 | 2,000 | 103,020 | 0 | 2 K to 0 (-100.00 %) |
Oct 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Oct 16 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | M | 11.20 | 1,500 | 16,800 | 7,188 | |
Oct 16 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 39.54 | 1,023 | 40,449 | 1,890 | 2.9 K to 1.9 K (-35.12 %) |
Oct 16 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 38.93 | 477 | 18,570 | 2,913 | 3.4 K to 2.9 K (-14.07 %) |
Oct 16 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Buy | M | 11.20 | 1,500 | 16,800 | 3,390 | 1.9 K to 3.4 K (+79.37 %) |
Sep 17 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | M | 11.20 | 1,500 | 16,800 | 8,688 | |
Sep 17 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 44.20 | 163 | 7,205 | 1,890 | 2.1 K to 1.9 K (-7.94 %) |
Sep 17 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 43.55 | 1,337 | 58,226 | 2,053 | 3.4 K to 2.1 K (-39.44 %) |
Sep 17 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Buy | M | 11.20 | 1,500 | 16,800 | 3,390 | 1.9 K to 3.4 K (+79.37 %) |
Sep 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 65,000 | |
Sep 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 42.58 | 2,000 | 85,160 | 0 | 2 K to 0 (-100.00 %) |
Sep 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Aug 19 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 67,000 | |
Aug 19 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 40.04 | 561 | 22,462 | 0 | 561 to 0 (-100.00 %) |
Aug 19 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 39.13 | 1,439 | 56,308 | 561 | 2 K to 561 (-71.95 %) |
Aug 19 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Aug 19 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | M | 11.20 | 1,500 | 16,800 | 10,188 | |
Aug 19 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 39.26 | 240 | 9,422 | 1,890 | 2.1 K to 1.9 K (-11.27 %) |
Aug 19 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 38.44 | 846 | 32,520 | 2,130 | 3 K to 2.1 K (-28.43 %) |
Aug 19 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 37.71 | 414 | 15,612 | 2,976 | 3.4 K to 3 K (-12.21 %) |
Aug 19 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Buy | M | 11.20 | 1,500 | 16,800 | 3,390 | 1.9 K to 3.4 K (+79.37 %) |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 69,000 | |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 44.58 | 500 | 22,290 | 0 | 500 to 0 (-100.00 %) |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 69,000 | |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 43.60 | 1,500 | 65,400 | 500 | 2 K to 500 (-75.00 %) |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 44.58 | 500 | 22,290 | 0 | 500 to 0 (-100.00 %) |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 43.60 | 1,500 | 65,400 | 500 | 2 K to 500 (-75.00 %) |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Jul 17 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | M | 11.20 | 1,500 | 16,800 | 11,688 | |
Jul 17 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 36.40 | 1,155 | 42,042 | 1,890 | 3 K to 1.9 K (-37.93 %) |
Jul 17 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 35.31 | 345 | 12,182 | 3,045 | 3.4 K to 3 K (-10.18 %) |
Jul 17 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Buy | M | 11.20 | 1,500 | 16,800 | 3,390 | 1.9 K to 3.4 K (+79.37 %) |
Jun 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 71,000 | |
Jun 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 43.42 | 984 | 42,725 | 0 | 984 to 0 (-100.00 %) |
Jun 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 42.59 | 1,016 | 43,271 | 984 | 2 K to 984 (-50.80 %) |
Jun 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Jun 17 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | A | 0.00 | 5,520 | 0 | 5,520 | |
Jun 17 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | M | 11.20 | 1,500 | 16,800 | 13,188 | |
Jun 17 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.00 | 1,890 | 0 | 0 | |
Jun 17 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 30.79 | 1,500 | 46,186 | 1,890 | 3.4 K to 1.9 K (-44.25 %) |
Jun 17 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Buy | M | 11.20 | 1,500 | 16,800 | 3,390 | 1.9 K to 3.4 K (+79.37 %) |
Jun 17 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Buy | M | 0.00 | 1,890 | 0 | 1,890 | 0 to 1.9 K |
May 18 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | M | 7.47 | 10,168 | 75,955 | 0 | |
May 18 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 31.20 | 3,715 | 115,908 | 0 | 3.7 K to 0 (-100.00 %) |
May 18 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Sell | S | 30.61 | 6,453 | 197,526 | 3,715 | 10.2 K to 3.7 K (-63.46 %) |
May 18 2020 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Buy | M | 7.47 | 10,168 | 75,955 | 10,168 | 0 to 10.2 K |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 73,000 | |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 36.10 | 398 | 14,368 | 0 | 398 to 0 (-100.00 %) |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 73,000 | |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 35.23 | 400 | 14,092 | 398 | 798 to 398 (-50.13 %) |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 36.10 | 398 | 14,368 | 0 | 398 to 0 (-100.00 %) |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 34.14 | 1,202 | 41,036 | 798 | 2 K to 798 (-60.10 %) |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 35.23 | 400 | 14,092 | 398 | 798 to 398 (-50.13 %) |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 34.14 | 1,202 | 41,036 | 798 | 2 K to 798 (-60.10 %) |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Apr 27 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 25,000 | 11,250 | 75,000 | |
Apr 27 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 29.77 | 25,000 | 744,250 | 0 | 25 K to 0 (-100.00 %) |
Apr 27 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 25,000 | 11,250 | 25,000 | 0 to 25 K |
Apr 27 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 25,000 | 11,250 | 75,000 | |
Apr 27 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 29.77 | 25,000 | 744,250 | 0 | 25 K to 0 (-100.00 %) |
Apr 27 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 25,000 | 11,250 | 25,000 | 0 to 25 K |
Feb 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | A | 31.71 | 8,888 | 281,838 | 8,888 | |
Jun 20 2019 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | A | 0.00 | 1,890 | 0 | 1,890 | |
Jun 20 2019 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | A | 26.45 | 3,857 | 102,018 | 3,857 | |
Mar 27 2019 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | A | 23.34 | 4,410 | 102,929 | 4,410 | |
Jan 04 2017 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | A | 22.30 | 8,611 | 192,025 | 8,611 | |
Jan 05 2016 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | A | 14.71 | 7,828 | 115,150 | 7,828 | |
Mar 03 2015 | NSTG | NanoString Technol ... | HERSHBERG ROBERT | Director | Option Exercise | A | 11.20 | 14,688 | 164,506 | 14,688 | |
Jan 23 2006 | DNDN | DENDREON CORP | HERSHBERG ROBERT | Sr. VP & Chief Medi ... | Grant | A | 5.50 | 11,250 | 61,875 | 15,724 | 4.5 K to 15.7 K (+251.45 %) |
Dec 10 2004 | DNDN | DENDREON CORP | HERSHBERG ROBERT | Sr. VP & Chief Medi ... | Option Exercise | A | 9.77 | 69,148 | 675,576 | 69,148 | |
Dec 10 2004 | DNDN | DENDREON CORP | HERSHBERG ROBERT | Sr. VP & Chief Medi ... | Option Exercise | A | 9.77 | 5,852 | 57,174 | 5,852 |
Page: 1